Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling

Psychological Medicine

Volumn 44, Issue 11, 2014, Pages 2309-2322

  Mehta, D ^a   Newport, D J ^b   Frishman, G ^c   Kraus, L ^a   Rex Haffner, M ^a   Ritchie, J C ^b   Lori, A ^b   Knight, B T ^d   Stagnaro, E ^b   Ruepp, A ^c   Stowe, Z N ^d   Binder, E B ^a,b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Biomarkers; Depression; Estrogen; Postpartum

Indexed keywords

BIOLOGICAL MARKER; TRANSCRIPTOME;

ADULT; BLOOD; DEPRESSION, POSTPARTUM; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMAN; LONGITUDINAL STUDY; METABOLISM; PHYSIOLOGY; PREGNANCY; THIRD TRIMESTER PREGNANCY;

ADULT; BIOMARKERS; DEPRESSION, POSTPARTUM; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY TRIMESTER, THIRD; TRANSCRIPTOME;

EID: 84903273155     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291713003231     Document Type: Article

References (53)

1. Albacar G, Sans T, Martin-Santos R, Garcia-Esteve L, Guillamat R, Sanjuan J, Canellas F, Carot JM, Gratacos M, Bosch J, Gaviria A, Labad A, Zotes AG, Vilella E (2010). Thyroid function 48 h after delivery as a marker for subsequent postpartum depression. Psychoneuroendocrinology 35, 738-742.
2. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, revised. American Psychological Association: Washington, DC.
3. Bailara KM, Henry C, Lestage J, Launay JM, Parrot F, Swendsen J, Sutter AL, Roux D, Dallay D, Demotes-Mainard J (2006). Decreased brain tryptophan availability as a partial determinant of post-partum blues. Psychoneuroendocrinology 31, 407-413.
4. Beck CT (1998). The effects of postpartum depression on child development: a meta-analysis. Archives of Psychiatric Nursing 12, 12-20.
5. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR (2004). Depression during pregnancy : overview of clinical factors. Clinical Drug Investigation 24, 157-179.
6. Bloch M, Aharonov I, Ben Avi I, Schreiber S, Amit A, Weizman A, Azem F (2011). Gonadal steroids and affective symptoms during in vitro fertilization: implication for reproductive mood disorders. Psychoneuroendocrinology 36, 790-796.
7. Bloch M, Rotenberg N, Koren D, Klein E (2005). Risk factors associated with the development of postpartum mood disorders. Journal of Affective Disorders 88, 9-18.
8. Bloch M, Rotenberg N, Koren D, Klein E (2006). Risk factors for early postpartum depressive symptoms. General Hospital Psychiatry 28, 3-8.
9. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR (2000). Effects of gonadal steroids in women with a history of postpartum depression. American Journal of Psychiatry 157, 924-930.
10. Brennan PA, Pargas R, Walker EF, Green P, Newport DJ, Stowe Z (2008). Maternal depression and infant cortisol: influences of timing, comorbidity and treatment. Journal of Child Psychology and Psychiatry 49, 1099-1107
11. Coppen A, Shaw DM, Herzberg B, Maggs R (1967). Tryptophan in the treatment of depression. Lancet ii, 1178-1180
12. Covington HE 3rd, Vialou V, Nestler EJ (2009). From synapse to nucleus: novel targets for treating depression. Neuropharmacology 58, 683-693.
13. Craddock N, Forty L (2006). Genetics of affective (mood) disorders. European Journal of Human Genetics 14, 660-668.
14. Deecher D, Andree TH, Sloan D, Schechter LE (2008). From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 33, 3-17.
15. Demetrio FN, Renno J Jr, Gianfaldoni A, Goncalves M, Halbe HW, Filho AH, Gorenstein C (2011). Effect of estrogen replacement therapy on symptoms of depression and anxiety in non-depressive menopausal women: a randomized double-blind, controlled study. Archives of Women's Mental Health 14, 479-486.
16. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C (2007). Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nuclear Medicine and Biology 34, 865-877.
17. Essex MJ, Klein MH, Cho E, Kalin NH (2002). Maternal stress beginning in infancy may sensitize children to later stress exposure: effects on cortisol and behavior. Biological Psychiatry 52, 776-784.
18. Feifel D (2006). When common clinical practice meets evidence-based medicine. Psychiatry (Edgmont) 3, 36-38.
19. Forty L, Jones L, Macgregor S, Caesar S, Cooper C, Hough A, Dean L, Dave S, Farmer A, McGuffin P, Brewster S, Craddock N, Jones I (2006). Familiality of postpartum depression in unipolar disorder: results of a family study. American Journal of Psychiatry 163, 1549-1553
20. Guintivano J, Arad M, Gould TD, Payne JL, Kaminsky ZA (2013). Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Molecular Psychiatry. Published online: 21 May 2013. doi:10.1038/mp.2013.62.
21. Holopainen D (2002). The experience of seeking help for postnatal depression. Australian Journal of Advanced Nursing 19, 39-44.
22. Hsiao CC, Liu CY, Hsiao MC (2004). No correlation of depression and anxiety to plasma estrogen and progesterone levels in patients with premenstrual dysphoric disorder. Psychiatry and Clinical Neurosciences 58, 593-599.
23. Inoue A,Yoshida N,OmotoY, Oguchi S,YamoriT, KiyamaR, Hayashi S (2002). Development of cDNA microarray for expression profiling of estrogen-responsive genes. Journal of Molecular Endocrinology 29, 175-192.
24. Katz ER, Stowe ZN, Newport DJ, Kelley ME, Pace TW, Cubells JF, Binder EB (2012). Regulation of mRNA expression encoding chaperone and co-chaperone proteins of the glucocorticoid receptor in peripheral blood: association with depressive symptoms during pregnancy. Psychological Medicine 42, 943-956.
25. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ (1992). A population-based twin study of major depression in women. The impact of varying definitions of illness. Archives of General Psychiatry 49, 257-266.
26. Kessler RC, Walters EE (1998). Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depression and Anxiety 7, 3-14.
27. Krishnan V, Nestler EJ (2010). Linking molecules to mood: new insight into the biology of depression. American Journal of Psychiatry 167, 1305-1320
28. Kuijpens JL, Vader HL, Drexhage HA, Wiersinga WM, van Son MJ, Pop VJ (2001). Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. European Journal of Endocrinology 145, 579-584.
29. Leung BM, Kaplan BJ (2009). Perinatal depression: prevalence, risks, and the nutrition link -a review of the literature. Journal of the American Dietetic Association 109, 1566-1575
30. Lokuge S, Frey BN, Foster JA, Soares CN, Steiner M (2011). Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin. Journal of Clinical Psychiatry 72, e1563-e1569.
31. Lommatzsch M, Hornych K, Zingler C, Schuff-Werner P, Hoppner J, Virchow JC (2006). Maternal serum concentrations of BDNF and depression in the perinatal period. Psychoneuroendocrinology 31, 388-394.
32. Maes M, Ombelet W, Verkerk R, Bosmans E, Scharpe S (2001). Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression. Psychological Medicine 31, 847-858.
33. Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpe S (2002). Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Life Sciences 71, 1837-1848
34. McCarthy M, McMahon C (2008). Acceptance and experience of treatment for postnatal depression in a community mental health setting. Health Care for Women International 29, 618-637.
35. Mehta D, Gonik M, Klengel T, Rex-Haffner M, Menke A, Rubel J, Mercer KB, Putz B, Bradley B, Holsboer F, Ressler KJ, Muller-Myhsok B, Binder EB (2011). Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Archives of General Psychiatry 68, 901-910.
36. Mitchell C, Notterman D, Brooks-Gunn J, Hobcraft J, Garfinkel I, Jaeger K, Kotenko I, McLanahan S (2011). Role of mother's genes and environment in postpartum depression. Proceedings of the National Academy of Sciences USA 108, 8189-8193
37. Ng RC, Hirata CK, Yeung W, Haller E, Finley PR (2010). Pharmacologic treatment for postpartum depression: a systematic review. Pharmacotherapy 30, 928-941.
38. O'Connor TG, Caprariello P, Blackmore ER, Gregory AM, Glover V, Fleming P (2007). Prenatal mood disturbance predicts sleep problems in infancy and toddlerhood. Early Human Development 83, 451-458.
39. O'Hara MW, Schlechte JA, Lewis DA, Varner MW (1991). Controlled prospective study of postpartum mood disorders: psychological, environmental, and hormonal variables. Journal of Abnormal Psychology 100, 63-73.
40. Orr ST, Miller CA (1995). Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings. Epidemiologic Reviews 17, 165-171.
41. Pawlby S, Hay DF, Sharp D, Waters CS, O'Keane V (2009). Antenatal depression predicts depression in adolescent offspring: prospective longitudinal community-based study. Journal of Affective Disorders 113, 236-243.
42. Quelopana AM, Champion JD, Reyes-Rubilar T (2011). Factors associated with postpartum depression in Chilean women. Health Care for Women International 32, 939-949.
43. Rahman A, Iqbal Z, Bunn J, Lovel H, Harrington R (2004). Impact of maternal depression on infant nutritional status and illness: a cohort study. Archives of General Psychiatry 61, 946-952.
44. Rubinow DR (2005). Reproductive steroids in context. Archives of Women's Mental Health 8, 1-5.
45. Rubinow DR, Hoban MC, Grover GN, Galloway DS, Roy-Byrne P, Andersen R, Merriam GR (1988). Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. American Journal of Obstetrics and Gynecology 158, 5-11.
46. Rubinow DR, Schmidt PJ, Roca CA (1998). Hormone measures in reproductive endocrine-related mood disorders: diagnostic issues. Psychopharmacology Bulletin 34, 289-290.
47. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. New England Journal of Medicine 338, 209-216.
48. Segman RH, Goltser-Dubner T, Weiner I, Canetti L, Galili-Weisstub E, Milwidsky A, Pablov V, Friedman N, Hochner-Celnikier D (2009). Blood mononuclear cell gene expression signature of postpartum depression. Molecular Psychiatry 15, 93-100
49. Sit D, Seltman H, Wisner KL (2011). Seasonal effects on depression risk and suicidal symptoms in postpartum women. Depression and Anxiety 28, 400-405.
50. Stewart DE, Boydell KM (1993). Psychologic distress during menopause: associations across the reproductive life cycle. International Journal of Psychiatry in Medicine 23, 157-162.
51. Terasaka S, Aita Y, Inoue A, Hayashi S, Nishigaki M, Aoyagi K, Sasaki H, Wada-Kiyama Y, Sakuma Y, Akaba S, Tanaka J, Sone H, Yonemoto J, Tanji M, Kiyama R (2004). Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environmental Health Perspectives 112, 773-781.
52. WHO (2008). The Global Burden of Disease: 2004 Update. World Health Organization: Geneva.
53. Yim IS, Glynn LM, Schetter CD, Hobel CJ, Chicz-Demet A, Sandman CA (2010). Prenatal beta-endorphin as an early predictor of postpartum depressive symptoms in euthymic women. Journal of Affective Disorders 125, 128-133.